JP2015504860A5 - - Google Patents

Download PDF

Info

Publication number
JP2015504860A5
JP2015504860A5 JP2014546154A JP2014546154A JP2015504860A5 JP 2015504860 A5 JP2015504860 A5 JP 2015504860A5 JP 2014546154 A JP2014546154 A JP 2014546154A JP 2014546154 A JP2014546154 A JP 2014546154A JP 2015504860 A5 JP2015504860 A5 JP 2015504860A5
Authority
JP
Japan
Prior art keywords
composition
emulsion
castor oil
dry eye
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014546154A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015504860A (ja
JP6142419B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/068615 external-priority patent/WO2013086449A1/en
Publication of JP2015504860A publication Critical patent/JP2015504860A/ja
Publication of JP2015504860A5 publication Critical patent/JP2015504860A5/ja
Application granted granted Critical
Publication of JP6142419B2 publication Critical patent/JP6142419B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014546154A 2011-12-07 2012-12-07 塩感受性エマルジョン系を用いたヒト涙液膜への効率的脂質送達 Active JP6142419B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161568089P 2011-12-07 2011-12-07
US61/568,089 2011-12-07
US201261625401P 2012-04-17 2012-04-17
US61/625,401 2012-04-17
PCT/US2012/068615 WO2013086449A1 (en) 2011-12-07 2012-12-07 Efficient lipid delivery to human tear film using a salt-sensitive emulsion system

Publications (3)

Publication Number Publication Date
JP2015504860A JP2015504860A (ja) 2015-02-16
JP2015504860A5 true JP2015504860A5 (https=) 2016-02-04
JP6142419B2 JP6142419B2 (ja) 2017-06-07

Family

ID=47459152

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014546154A Active JP6142419B2 (ja) 2011-12-07 2012-12-07 塩感受性エマルジョン系を用いたヒト涙液膜への効率的脂質送達

Country Status (27)

Country Link
US (2) US9314528B2 (https=)
EP (5) EP3666257A1 (https=)
JP (1) JP6142419B2 (https=)
KR (1) KR102017922B1 (https=)
CN (2) CN104114152A (https=)
AR (1) AR089123A1 (https=)
AU (2) AU2012347459A1 (https=)
BR (1) BR112014013820A8 (https=)
CA (1) CA2858574C (https=)
CL (1) CL2014001518A1 (https=)
CO (1) CO6990739A2 (https=)
DK (2) DK2787968T3 (https=)
ES (2) ES2896336T3 (https=)
HU (2) HUE057140T2 (https=)
IL (1) IL233008A (https=)
IN (1) IN2014CN04809A (https=)
MX (1) MX355216B (https=)
MY (1) MY173378A (https=)
PH (2) PH12014501296B1 (https=)
PL (2) PL2787969T3 (https=)
PT (2) PT2787968T (https=)
RU (1) RU2014127074A (https=)
SG (1) SG11201403013VA (https=)
SI (2) SI2787968T1 (https=)
TW (1) TWI652072B (https=)
WO (2) WO2013086449A1 (https=)
ZA (1) ZA201404228B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8957048B2 (en) * 2011-10-06 2015-02-17 Allergan, Inc. Compositions for the treatment of dry eye
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
EP3266446B1 (en) 2016-07-07 2018-11-21 Laboratorios SALVAT, S.A. Ophthalmic composition comprising castor oil and medium chain triglyceride
US11903986B2 (en) 2016-08-19 2024-02-20 Akrivista Llc Methods of diagnosing and treating dry eye syndrome and compositions for treating a human eye
CN114376961A (zh) 2017-08-18 2022-04-22 阿克里维斯塔有限责任公司 诊断和治疗干眼综合症的方法和用于治疗人类眼睛的组合物
AU2019261437B2 (en) 2018-04-27 2024-11-07 Allergan, Inc. Sodium chlorite compositions with enhanced anti-microbial efficacy and reduced toxicity
WO2025175150A1 (en) * 2024-02-16 2025-08-21 Allergan, Inc. Enhanced artificial tear formulations

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4201706A (en) 1978-09-22 1980-05-06 Burton, Parsons & Company, Inc. Treatment of corneal edema
ATE6466T1 (de) * 1979-10-26 1984-03-15 Smith And Nephew Associated Companies P.L.C. Autoklavierbare emulsionen.
US5192535A (en) 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
IT1224795B (it) 1988-12-01 1990-10-24 Sigma Tau Ind Farmaceuti Uso dell'acetil d-carnitina nel trattamento terapeutico del glaucoma e composizioni farmaceutiche utili in tale trattamento
DE436726T1 (de) 1989-08-03 1992-02-06 Eisai Co., Ltd., Tokio/Tokyo Verfahren zur photostabilisierung von augenspuelloesungen sowie photostabilisierte augenspuelloesung.
US5681555A (en) 1991-04-22 1997-10-28 Gleich; Gerald J. Method for the treatment of bronchial asthma by parenteral administration of anionic polymers
DE4229494A1 (de) 1992-09-04 1994-03-10 Basotherm Gmbh Arzneimittel zur topischen Anwendung am Auge zur Behandlung des erhöhten intraokularen Drucks
EP0778021A4 (en) 1994-09-14 1998-06-03 Taisho Pharmaceutical Co Ltd DROPS TO CARE FOR THE CORNEA
US5980865A (en) 1995-08-18 1999-11-09 Baker Norton Pharmaceuticals, Inc. Method for treating late phase allergic reactions and inflammatory diseases
FI106923B (fi) 1997-01-03 2001-05-15 Cultor Ltd Finnsugar Bioproduc Trimetyyliglysiinin käyttö kehon limakalvojen hygieniaan ja hoitoon tarkoitetuissa valmisteissa
AR002194A1 (es) 1997-03-17 1998-01-07 Sanchez Reynaldo Alemany Instrumento computarizado para el analisis del movimiento.
IT1302307B1 (it) 1998-09-01 2000-09-05 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil
AU1295200A (en) 1998-11-13 2000-06-05 Continental Projects Limited Complexes of hyaluronic acid/carnitines and pharmaceutical and cosmetic compositions
JP2000159659A (ja) * 1998-11-30 2000-06-13 Kazuo Tsubota 眼科用人工涙液
US6228392B1 (en) 1999-04-29 2001-05-08 Gene Tools, Llc Osmotic delivery composition, solution, and method
CA2416169C (en) 2000-07-14 2008-09-23 Allergan, Inc. Compositions containing therapeutically active components having enhanced solubility
CA2355814C (en) 2000-09-14 2010-06-29 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Pharmaceutical composition for ophthalmic use
WO2002038161A1 (en) 2000-11-08 2002-05-16 Bio-Concept Laboratories Improved ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers
US7045121B2 (en) 2001-12-14 2006-05-16 Allergan, Inc. Ophthalmic compositions for lubricating eyes and methods for making and using same
US7795203B2 (en) 2002-09-30 2010-09-14 Babizhayev Mark A Method for topical treatment of eye disease and composition and device for said treatment
AU2003301263A1 (en) * 2002-10-18 2004-05-04 Joel S. Echols Three layer tear formulation
US20040137079A1 (en) 2003-01-08 2004-07-15 Cook James N. Contact lens and eye drop rewetter compositions and methods
US6635654B1 (en) * 2003-01-09 2003-10-21 Allergan, Inc. Ophthalmic compositions containing loratadine
US20040185068A1 (en) * 2003-03-18 2004-09-23 Zhi-Jian Yu Self-emulsifying compositions, methods of use and preparation
JPWO2004084877A1 (ja) 2003-03-26 2006-06-29 株式会社メニコン 眼科用組成物
TWI336257B (en) * 2003-06-13 2011-01-21 Alcon Inc Ophthalmic compositions containing a synergistic combination of three polymers
AU2004249137B2 (en) * 2003-06-13 2010-03-11 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
US20050009836A1 (en) 2003-06-26 2005-01-13 Laskar Paul A. Ophthalmic composition containing quinolones and method of use
EP1683528A4 (en) * 2003-11-10 2011-07-27 Toray Industries POLYSACCHARIDE-CONTAINING COMPOSITION AND OPHTHALMIC SOLUTION FOR STABILIZING THE TISSUE FILM
US8569367B2 (en) * 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
US7288520B2 (en) * 2005-07-13 2007-10-30 Allergan, Inc. Cyclosporin compositions
US7501393B2 (en) * 2005-07-27 2009-03-10 Allergan, Inc. Pharmaceutical compositions comprising cyclosporins
US9561178B2 (en) * 2006-07-25 2017-02-07 Allergan, Inc. Cyclosporin compositions
WO2008035246A2 (en) * 2006-07-28 2008-03-27 Novagali Pharma Sa Compositions containing quaternary ammonium compounds
CN101896160A (zh) * 2006-10-17 2010-11-24 阿勒根公司 环胞菌素组合物
CN101668511A (zh) * 2007-02-28 2010-03-10 阿西克斯医疗公司 正常化睑板腺分泌的方法和化合物
JP4929245B2 (ja) 2008-07-31 2012-05-09 株式会社ベッセル工業 工具類のグリップ
US8496976B2 (en) 2009-06-05 2013-07-30 Allergan, Inc. Artificial tears and therapeutic uses
WO2013049621A1 (en) * 2011-09-29 2013-04-04 The Board Of Regents Of The University Of Oklahoma Ophthalmic compositions comprising ppar-alpha agonists and methods of production and use thereof
US8957048B2 (en) 2011-10-06 2015-02-17 Allergan, Inc. Compositions for the treatment of dry eye

Similar Documents

Publication Publication Date Title
JP2015504860A5 (https=)
JP2010538011A5 (https=)
JO3680B1 (ar) تركيبات صيدلانية موضعية
RU2015141767A (ru) Композиции и способы для местной доставки простагландинов в подкожный жир
BR112015019657A2 (pt) composições tópicas e métodos de uso das mesmas
EA201291108A1 (ru) Фармацевтические композиции в виде эмульсии с низким содержанием масла, содержащие прогестоген
TR201904455T4 (tr) Nükleer taşıma modülatörleri olarak 1,2,4-triazoller ve bunların kullanımları.
JP2015531344A5 (https=)
AR084932A1 (es) Composicion oftalmica que comprende un androgeno y su uso para la fabricacion de un medicamento util para el tratamiento de una enfermedad ocular resultante de una deficiencia androgenica
MY180145A (en) Cenicriviroc compositions and methods of making and using the same
NZ629045A (en) Topical compositions comprising fipronil and permethrin and methods of use
WO2017022962A8 (ko) Ripk 억제제를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물
RU2014127074A (ru) Состав для эффективной доставки липидов в слезную пленку человека с использованием чувствительной к соли эмульсионной системы
RU2016135039A (ru) Композиция для обработки поверхностных дефектов
EA201691490A1 (ru) Фармацевтическая композиция, содержащая бринзоламид
CO7101247A2 (es) Formulaciones de ácido poliinosínico-policitidílico (poli(i:c)) para el tratamiento de infecciones de las vías respiratorias altas
RU2019139886A (ru) Терапевтическое средство против дисфункции мейбомиевых желез
JP2016502979A5 (https=)
EA201591653A1 (ru) Композиции для лечения глазных расстройств с применением дипиридамола
BR112015001627A2 (pt) composição farmacêutica, respectivos usos e método para diminuir a frequência de micção
GEP201706644B (en) Insecticidal water-in-oil (w/o) formulation
BR112017014016A2 (pt) método de redução da pressão intraocular, e, composição farmacêutica.
FI3373976T3 (fi) Topikaalisia formulaatioita ja niiden käyttöjä
EA201200754A1 (ru) Традиционное китайское лекарственное средство, содержащее экстракты дан-шен (danshen) и сан-ки (sanqi), и его применение
WO2019004788A3 (ko) 브라우쏘칼콘 a를 유효성분으로 포함하는 염증성 장질환 예방 또는 치료용 약학 조성물